The importance of motion diagnostics to promote early physical activity in children with rheumatic diseases

Organizational Data

DRKS-ID:
DRKS00017272
Recruitment Status:
Recruiting ongoing
Date of registration in DRKS:
2019-05-29
Last update in DRKS:
2022-07-12
Registration type:
Retrospective

Acronym/abbreviation of the study

Beware

URL of the study

https://www.rheuma-kinderklinik.de/rheuma-zentrum/so-behandeln-wir/bewegungsanalyse/beware-projekt

Brief summary in lay language

Approximately 1,500 children and adolescents develop a juvenile type of rheumatism, the Juvenile Idiopathic Arthritis, in Germany each year. The inflammations in the joints affect everyday functionality, quality of life as well as physical activity. Despite significant improvements in drug treatment, around one-quarter of affected adolescents face long-term restrictions on everyday movements. It is believed that some of these long-term consequences can be avoided by appropriate movement support. However, there is uncertainty among physicians regarding the use of functional diagnostics to assess sports participation and the earliest possible use of active exercise therapy together with sport. As part of the project, special motion analysis will be used and an IT-based sports recommendation tool for children with rheumatism will be developed. In addition, the effect of this early sports recommendation is examined in comparison to the currently often practiced sports partial exemption. 125 children and adolescents with rheumatism will be medically assisted for up to two years and examined two to three times. In half of these children, the differentiated sports advice (sports advice tool) is used. The comparison group receives a standard care and recommendation for sport. Health status, motor performance and quality of life are compared. After successful completion of the study, pediatric rheumatologists and paediatricians in the German-speaking area should be provided with a counseling tool to advise all affected children and adolescents on the right and safe sports to prevent long-term restrictions.

Brief summary in scientific language

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children and adolescents with predominant involvement of the joints and tendons. The disease often causes a circle of pain and inflammation, leading to functional restraints, muscular imbalances and restrictions in everyday movements as well as specific malpositions. In addition, this often results in an increase in physical and athletic inactivity with long-term deficits in motor abilities, which also persist after an inactive disease status. The patients bear a long-term increased risk of misuse and overloading of the musculoskeletal system, which increase distinctively, especially during sports, movements. In addition to the personal (psycho-social) perspective of the patients, a corresponding risk assessment of functional deficits is also of crucial importance in terms of health economics. Established children's rheumatism scores do not consider this, so that in addition to the clinical diagnostics movement diagnostics should be used. The results of the risk assessment of functional deficits can flow into an individual sports recommendation. There is an urgent need for research. The protocol of the planned prospective cohort and intervention study aims to evaluate criteria for the use of appropriate functional diagnostic methods with sports recommendation for JIA patients. Project results are indication criteria that lead to a more efficient use of resources in functional diagnostics, and a computer-based sports recommendation tool. Above all, the need-based care of patients with functional limitations should benefit. The goals are to improve the motor skills and quality of life of these patients. The study is conducted at the German Center for Pediatric and Adolescent Rheumatology (DZKJR). A mixed methods approach with randomized control group design for effects checking quantitative and qualitative data collections as well as an exploratory study design for the identification of functional deficits will be chosen. In addition, at the end of the study there will be a health economic evaluation of the costs and benefit parameters. About 125 newly diseased JIA patients with at least one actively affected joint will be recruited for 36 months and examined clinically as well as motion diagnostically on at two to three inpatient hospital stays. The established methods of three-dimensional (3D) motion analysis and the Deutsche Motorik Test (DMT) are used for differentiated motion diagnostics. Patients can be enrolled at two points in the study. At t0, newly diagnosed JIA-Patients with at least one affected joint aged 6-16 years can are included and will take part in three clinical visits t0, t1, t2 (stays are independent of the study). A change of protocol was made to also include pre-treated patients to enter the study at t1. Patients have to reach an inactive state of disease and fulfil the inclusion criteria of t0 in hindsight, as if they would have been at the clinic earlier (t0). From that point on (t1/t1’), this cohort (t1’) will fulfil the same study protocol as the patients included at t0. At t1/t1’, a stratified randomization into two intervention groups takes place with the onset of an inactive disease phase. This measurement will take place up to 14 months after t0 or at the point of inclusion for t1’-patients. Patients, who were included at t0, have to be checked for an inactive state of disease after max. 12 months. Then, they have an additional two months to come back to the clinic. This extension was made due to the Covid-19 pandemic. One of the intervention groups receives an individual sports recommendation based on the results of the movement diagnostics and the subjective self-assessment of the patient as well as the assessment of the therapist / tester (intervention a). There is a comparison to the group with a current standard sport recommendation (intervention b, general description of sport limitations). At the last measurement, the motor performance change will be checked within 3-9 months in both intervention groups. The duration of the intervention phase was extended from 3-6 to 3-9 months due to Covid-19. At this appointment, all patients receive individual sports advice (intervention a). In order to monitor the state of health and physical activity in the phases between hospital stays, patients take weekly/monthly surveys using TUM / DZKJR’s own WebApp. Since May 2020 an additional questionnaire is used to examine constraints regarding their physical activity during the intervention phase due to the Covid-19 pandemic. The primary endpoint of the study is to improve the function of JIA patients with a functional deficit through optimal sports recommendation. The secondary endpoint is a consistent minimal inflammatory activity and pain intensity as well as an improvement in health-related quality of life. At the end of the study, the sports recommendation tool will be adjusted on the basis of the study results and transferred to a software application.

Health condition or problem studied

ICD10:
M08.0 - Juvenile rheumatoid arthritis
ICD10:
M08.2 - Juvenile arthritis with systemic onset
ICD10:
M08.3 - Juvenile polyarthritis (seronegative)
ICD10:
M08.4 - Pauciarticular juvenile arthritis
ICD10:
M08.8 - Other juvenile arthritis
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
At the clinical visit t1/t1', the study group is divided into two groups with a stratified randomization. Arm 1 receives an individual sports advice and recommendation based on the results of the motion diagnostics and the subjective self-assessment of the patient as well as the assessment of the therapist / tester. Within 3-9 months, the changes in the motor performance will be checked in both intervention groups (t2).
Arm 2:
Arm 2 receives a standard sports recommendation at the clinical visit t1/t1'. Changes in the motor performance will be examined after 3-9 months. At the last clinical visit (t2) arm 2 receives an individual sports advice and recommendation as arm 1.

Endpoints

Primary outcome:
The primary endpoint in this study is the functional improvement of JIA patients with a functional deficit through an optimal sports recommendation. The parameters are collected at the measurement t1/t1' and t2. Changes are quantified with a fitness test (Deutscher Motorik-Test).
Secondary outcome:
The secondary endpoint is a consistent minimal inflammatory activity and pain intensity as well as an improvement in health-related quality of life. The parameters are recorded at t1/t1' and t2 in the clinic. For this purpose, clinical parameters and subjective parameters of a patient survey are used.

Study Design

Purpose:
Treatment
Allocation:
Randomized controlled study
Control:
  • Active control (effective treatment of control group)
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
Yes
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
  • Assessor

Recruitment

Recruitment Status:
Recruiting ongoing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • Medical center Deutsches Zentrum für Kinder- und Jugendrheumatologie Garmisch-Partenkirchen

Recruitment period and number of participants

Planned study start date:
2019-05-06
Actual study start date:
2019-05-06
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
125
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
All
Minimum Age:
6 Years
Maximum Age:
16 Years
Additional Inclusion Criteria:
T0: • Diagnosis of a JIA according to ILAR criteria (Petty et al., 2004) • new disease (shorter than 12 months) • Pre-treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) and cortisone (maximum 0.2 mg / kg body weight prednisolone equivalent) is possible • Active JIA disease according to Wallace et al., 2004 • Age from 6 to 16 years • Involvement of the lower and / or upper limb and / or the spine • German Speaking T1': • Diagnosis of a JIA according to ILAR criteria (Petty et al., 2004), inactive state of disease (cJADAS 10: oligo ≤1.5, polyartikulär ≤2.5) • duration of disease at first visit to a pediatric rheumatoligist ≤ 12 months, 6-months intervals of rheumatological screenings after first diagnosis, total duration of disease ≤ 24 months at t1' • Pre-treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) and cortisone (maximum 0.2 mg / kg body weight prednisolone equivalent) is possible • Age from 6 to 17years • Involvement of the lower and / or upper limb and / or the spine • German Speaking

Exclusion Criteria

T0: • Pre-treatment with Conventional Disease Modifying Anti-Rheumatic Drugs (cDMARDs) > 3 months and Biological Disease Modifying Anti-Rheumatic Drugs (bDMARDs) > 3 months • Chronic pain disorder • Neurological diseases • abnormalities of cognitive function • No interest • Pretreatment with cortisone> 0.2 mg / kg body weight prednisolone equivalent • Participation in other interventional studies T1': • Already participating at t0 • Pre-treatment with Conventional Disease Modifying Anti-Rheumatic Drugs (cDMARDs) > 15 months and Biological Disease Modifying Anti-Rheumatic Drugs (bDMARDs) > 15 months • intra-articular injection (<4 weeks ago) • Chronic pain disorder • Neurological diseases • abnormalities of cognitive function • No interest • Pretreatment with cortisone> 0.2 mg / kg • Participation in other interventional studies

Addresses

Primary Sponsor

Address:
Professur für Biomechanik im Sport, Fakultät für Sport- und Gesundheitswissenschaften, Technische Universität München
Prof. Dr. Ansgar Schwirtz
Georg-Brauchle-Ring 60/62
80992 München
Germany
Telephone:
089 289 24580
Fax:
089 289 24582
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.sg.tum.de/
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Professur für Biomechanik im Sport, Fakultät für Sport- und Gesundheitswissenschaften, Technische Universität München
Dr. Josephine Gizik
Georg-Brauchle-Ring 60/62
80992 München
Germany
Telephone:
089 289 24648
Fax:
089 289 24582
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.sg.tum.de/

Contact for Public Queries

Address:
Deutsches Zentrum für Kinder- und Jugendrheumatologie
Matthias Hartmann
Gehfeldstr. 24
82467 Garmisch-Partenkirchen
Germany
Telephone:
08821 701 1550
Fax:
08821 701 9101
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.rheuma-kinderklinik.de

Principal Investigator

Address:
Professur für Biomechanik im Sport, Fakultät für Sport- und Gesundheitswissenschaften, Technische Universität München
Dr. Josephine Gizik
Georg-Brauchle-Ring 60/62
80992 München
Germany
Telephone:
089 289 24648
Fax:
089 289 24582
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.sg.tum.de/

Sources of Monetary or Material Support

Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)

Address:
DLR Projektträger, Bereich Gesundheit, Abteilung Gesundheitswesen, Versorgungsforschung
Heinrich-Konen-Straße 1
53227 Bonn
Germany
Telephone:
0228-3821-1877
Fax:
0228 3821-1257
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.dlr.de/pt

Ethics Committee

Address Ethics Committee

Address:
Ethikkommission der Fakultät für Medizin der Technischen Universität München
Ismaninger Str. 22
81675 München
Germany
Telephone:
+49-89-41404371
Fax:
+49-89-41404199
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2019-03-19
Ethics committee number:
143/19 S
Vote of the Ethics Committee:
Approved
Date of the vote:
2019-05-02

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No Entry
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry